Biomine Health

microbiome Immune Checkpoint cancer immunotherapy

Biomine Health is building a microbiome-based platform designed to improve how patients are selected and monitored for cancer immunotherapy. By analysing gut microbiome signatures linked to treatment response, their platform aims to help predict which patients are more likely to benefit from immune checkpoint inhibitors, supporting better stratification in clinical trials and, ultimately, more personalised care. Alongside this, Biomine also offers a gut microbiome test for consumers and practitioners, translating complex microbial data into clear, actionable insights that help people better understand and improve their health and longevity.